Supporting the lives of dialysis patients

Almost 60 years have passed since the first perfusion solution for artificial kidneys was introduced in 1964.
As a dialysis specialty pharmaceutical company, we support dialysis patients using dialysate and other dialysis-related products.

In 1968, there were 215 dialysis patients in the country, and today, there are approximately 350,000 dialysis patients^*1. Times have changed; as the number of dialysis patients has grown, so has the environment in which they are treated.

The standards for dialysis therapy have changed over time as equipment has become more sophisticated and new drugs have been developed. We responded quickly to this trend by developing and launching more than 30 different dialysis solutions^*2 and promoting dialysis-related products for optimal dialysis treatment.

As a pioneer and market leader in dialysis solutions, we will continue to improve patients’ lives by developing patient-friendly dialysis solutions and dialysis-related products.

dialysate

Supporting healthcare through infusion

We have been producing the water of life for nearly 80 years.
Today, we offer a wide range of infusions and injections, from small to large, and produce essential medicines that support healthcare.

Having started our pharmaceutical production with glucose injections, we not only focused on developing the ingredients of the infusions but also on developing the containers into which the infusions are filled.

As infusions are used across many medical fields, to reduce the risk of medical errors and make them safer to use, we are working to develop containers that allow people to “recognize the product by looking at the container,” for example by placing an identification sticker on the rubber stopper part of the container and designing containers that make it easier to identify the concentration and ingredients.

We will continue to produce infusions that everyone can use with confidence.

infusion and injection products

Supporting patient’s life with a stable supply

Dialysis requires regular and continuous treatment. Infusions and injections are used in all types of treatments.
Therefore, our social responsibility to ensure a stable supply of these medicines to patients, as they are an essential part of healthcare.

Distributed distribution centers

We strive to reduce the risk of supply disruptions due to natural disasters by stockpiling medicines in 12 decentralized distribution centers across the country; thus, we can deliver them in all circumstances and situations.

Stable Supply of Medicines

Decentralization of production sites

Dialysate, infusion, and injection products are manufactured at the Joto, Okayama, and Ibaraki factories.
We diversified our risks in the event of a disaster by having production facilities in both eastern and western Japan.
Each factory is equipped with an automated multi-story warehouse to prepare for the risk of supply disruption.

Introduction of Production Bases

We stand together as one when disaster occurs.

Japan has been affected by several serious disasters, but under the slogan “Never Miss a Supply,” our employees have worked together to ensure a stable supply under all circumstances.

We will Supporting patients’ lives by delivering our products without interruption.

Now, a new step forward. ――

Nurturing the life yet to be born

Having expanded our business around the idea of “Supporting Life,” we entered the field of assisted reproductive technology in 2000 with the launch of HFF99, the first domestically produced embryo culture fluid.

Collaborating with the Japanese Society of Oocyte Research in 2017, we launched HiGROW OVIT, an embryo culture fluid with an unprecedented amino acid composition patented in 14 countries worldwide based on a detailed analysis of the composition of human oocyte fluid. And this is a great opportunity, expanded our business under a new unified brand, HiGROW.
We now offer nine assisted reproduction products for use across the fertility continuum.

We will combine our past experiences with new technologies to develop products that nurture the life that is yet to be born.

assisted reproduction products

• The Japanese Society for Dialysis Therapy
• This will be the sum of all dosage forms, all compositions, and all volumes.